INTRIVICI, Chiara
INTRIVICI, Chiara
4843delC of the BRCA1 gene is a possible founder mutation in Southern Italy (Sicily).
2007-01-01 RUSSO A; CALO V; AUGELLO C; BRUNO L; AGNESE V; SCHIRO V; BARBERA F; CASCIO S; FODDAI E; BADALAMENTI G; INTRIVICI C; CAJOZZO M; GULOTTA G; SURMACZ E; COLUCCI G; GEBBIA N; BAZAN V
A case of guillain-barre syndrome in a patient with non small cell lung cancer treated with chemotherapy
2006-01-01 CICERO G; FULFARO F; CARACENI A; ARCARA C; BADALAMENTI G; INTRIVICI C; GEBBIA N
A case report of inflammatory pseudotumor of the liver
2006-01-01 ARCARA C; SANDONATO L; FULFARO F; VIZZINI L; INTRIVICI C; TRAVAGLIATO MG; GEBBIA N
Aberrant methylation within RUNX3 CpG island associated with the nuclear and mitochondrial microsatellite instability in sporadic gastric cancers. Results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study.
2007-01-01 GARGANO, G; CALCARA, D; CORSALE, S; AGNESE, V; INTRIVICI, C; FULFARO, F; PANTUSO, G; CAJOZZO, M; MORELLO, V; TOMASINO, RM; OTTINI, L; COLUCCI, G; BAZAN, V; RUSSO, A
Aurora-A overexpression as an early marker of reflux-related columnar mucosa and Barrett's oesophagus.
2007-01-01 AGNESE, V; CABIBI, D; CALCARA, D; TERRASI, M; PANTUSO, G; FIORENTINO, E; INTRIVICI, C; COLUCCI, G; ARAGONA, F; GEBBIA, N; BAZAN, V; RUSSO, A
Autoimmunity predicts prolonged survival in colon cancer patients undergoing GOLFIG biochemotherapy.
2007-01-01 P CORREALE; P TAGLIAFERRI; F MONTAGNANI; C REMONDO; C INTRIVICI; FULFARO F; K Y TSANG; P TASSONE; M S ROTUNDO; S VENUTA; G FRANCINI
BRCA1 genetic testing in 106 breast and ovarian cancer families from southern Italy (Sicily): a mutation analyses.
2007-01-01 RUSSO A; CALO V; AGNESE V; BRUNO L; CORSALE S; AUGELLO C; GARGANO G; BARBERA; F; CASCIO S; INTRIVICI C; RINALDI G; GULOTTA G; MACALUSO M; SURMACZ E; GIORDANO; A; GEBBIA N; BAZAN V
Gastrointestinal stromal tumors (GISTs): focus on histopathological diagnosis and biomolecular features
2007-01-01 BADALAMENTI, G; RODOLICO, V; FULFARO, F; CASCIO, S; CIPOLLA, C; CICERO, G; INCORVAIA, L; SANFILIPPO, M; INTRIVICI, C; SANDONATO, L; PANTUSO, G; LATTERI, M; GEBBIA, N; RUSSO, A
Gemcitabine (GEM) plus oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX-4) in patients with advanced gastric cancer.
2005-01-01 CORREALE P; FULFARO F; MARSILI S; CICERO G; BAJARDI E; INTRIVICI C; VUOLO G; CARLI AF; CARAGLIA M; DEL PRETE S; GRECO E; GEBBIA N; FRANCINI G
Gemcitabine plus metronomic 5-fluorouracil or capecitabine as a second-/third-line chemotherapy in advanced adrenocortical carcinoma: a multicenter phase II study.
2010-01-01 Sperone, P; Ferrero, A; Daffara, F; Priola, A; Zaggia, B; Volante, M; Santini, D; Vincenzi, B; Badalamenti, G; Intrivici, C; Del Buono, S; De Francia, S; Kalomirakis, E; Ratti, R; Angeli, A; Dogliotti, L; Papotti, M; Terzolo, M; Berruti, A
La terapia adiuvante nel carcinoma del colon: un update della lettaratura
2004-01-01 FULFARO F; BAJARDI E; BADALAMENTI E; VALERIO MR; CICERO G; ARCARA C; RINALDI G; VIZZINI L; INTRIVICI C; LATTERI MA; GEBBIA N
Low dose oral chemotherapy for hormone refractory prostate carcinoma estramustine phosphate versus estramustine phosphate and etoposide. A Randomized phase II study of GSTU foundation
2006-01-01 VALERIO MR; CICERO G; SCIBILIA C; ADILE C; CROSTA A; ARCARA C; BADALAMENTI G; VIZZINI L; SPINNATO F; INTRIVICI C; FULFARO F
Molecular detection of TP53, Ki-Ras and p16INK4A promoter methylation in plasma of patients with colorectal cancer and its association with prognosis. Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study.
2006-01-01 BAZAN V; BRUNO L; AUGELLO C; AGNESE V; CALO V; CORSALE S; GARGANO G; TERRASI; M; SCHIRO V; DI FEDE G; ADAMO V; INTRIVICI C; CROSTA A; RINALDI G; LATTERI F; DARDANONI G; GRASSI N; VALERIO MR; COLUCCI G; MACALUSO M; RUSSO A
Pegylated Liposomal Doxorubicin and weekly paclitaxel as first line treatment in metastatic breast cancer
2004-01-01 BADALAMENTI G; VALERIO MR; RINALDI G; ARCARA C; CICERO G; VIZZINI L; TRAVAGLIATO MG; INTRIVICI C; RUSSO A; GULOTTA G; GEBBIA N; FULFARO F
The use of pegylated liposomal doxorubicin (PLD) in association with weekly paclitaxel as second line therapy in metastatic bladder carcinoma: final results
2010-01-01 Albanese, GV; Pizzo, T; Galvano, A; Piazza, D; Macaluso, S; Provenzano, S; Badalamenti, G; Intrivici, C; Fulfaro, F; Gebbia, N
The use of somatostatin analogues in metastatic hormone refractory and chemo resistant prostate cancer with neuroendocrine differentiation.
2005-01-01 INTRIVICI C; VIZZINI L; TRAVAGLIATO MG; PIZZO T; BADALAMENTI G; ARCARA C; CICERO G; RINALDI G; CROSTA A; SPINNATO F; VALERIO MR; FULFARO F
The use of zoledronic acid in patients with bone metastases from prostate carcinoma: effect on analgesic response and bone metabolism biomarkers
2005-01-01 FULFARO F; LETO G; BADALAMENTI G; ARCARA C; CICERO G; VALERIO MR; DI FEDE G; RUSSO A; VITALE A; RINI GB; CASUCCIO A; INTRIVICI C; GEBBIA N
Weekly Paclitaxel (T) and pegylated liposomal Doxorubicin (PLD) as first line treatment in metastatic breast cancer (MBC) patients.VII CONGRESSO NAZIONALE G.O.I.M. ROMA 23-25 Giugno 2004
2004-01-01 FULFARO F; VALERIO MR; BADALAMENTI G; ARCARA C; CICERO G; RINALDI G; ACCARDO A; INTRIVICI C; CROSTA A; SCIBILIA C; RUSSO A; DI FEDE G; GEBBIA N
“Serum HER-2/neu (s-HER2) levels evaluation in breast cancer (BC) patients (PTS)”
2008-01-01 PALMERI L; MANGIAMELI A; VAGLICA M; FRAZZETTA M; VETRI G; DI NOTO L; RAIMONDI C; ACCARDO A; BONGIOVANNI A; INTRIVICI C; PALMERI S